Improvement in vertigo frequency · Ménière’s disease
It is very uncertain whether betahistine changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
2 findings from 1 review
Vertigo (global score) at < 3 months · Ménière’s disease
1 finding from 1 review
Change in vertigo frequency · Ménière’s disease
2 findings from 1 review
Serious adverse events · Ménière’s disease
It is very uncertain whether betahistine changes serious adverse events compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Tinnitus loudness · patients with subjective idiopathic tinnitus
2 findings from 1 review
Other adverse effects (yes or no) · patients with subjective idiopathic tinnitus
2 findings from 1 review
Change in tinnitus loudness match (range 0 to 5) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Significant adverse events · patients with subjective idiopathic tinnitus
1 finding from 1 review
Tinnitus symptom severity · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Depressive symptoms · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Symptoms of generalised anxiety · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Other adverse effects (yes or no) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Change in tinnitus loudness measured by a visual analogue scale (range 0 to more than 10) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Significant adverse events · patients with subjective idiopathic tinnitus
2 findings from 1 review
Change in Tinnitus Severity Index (range 0 to 56) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Tinnitus symptom severity · patients with subjective idiopathic tinnitus
1 finding from 1 review
Depressive symptoms · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Symptoms of generalised anxiety · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Benefits · patients with symptoms of vertigo
The review found no eligible studies for this question.
1 finding from 1 review
Proportion of patients with improvement according to global judgement of patient subgrouped by diagnosis№ of participants: 606(11 RCTs) · patients with symptoms of vertigo
Betahistine may leads to higher proportion of patients with improvement according to global… compared with placebo (low certainty).
1 finding from 1 review